Press Information & Media Contact

CASP is a 501(c)(6) trade association — a legal designation that exists to advance the business interests of its dues-paying members. It is not a 501(c)(3) public charity. This distinction is material to every policy decision payers and regulators are being asked to make based on CASP's advocacy.

As of the date of this statement, every member of CASP's Board of Directors simultaneously holds an executive leadership role at a CASP member organization. There are no independent board members. This is documented on casproviders.org/staff-and-board.

CASP describes ACQ on its own website as "a wholly-owned subsidiary of CASP." CASP's CEO publicly stated in early 2026 that ACQ "wouldn't have been able to make ends meet" without CASP's direct financial support — contradicting CASP's public claims of ACQ independence.

CASP's own advocacy page — casproviders.org/advocacy — explicitly identifies mandatory RBT enrollment requirements in Indiana Medicaid as a named policy barrier CASP deployed lobbyists to defeat. This is CASP's own published documentation.

CASP fully acquired Jade Health — parent company of BHCOE and the National Autism Data Registry — consolidating two accreditation programs and a national patient-level data repository under a single trade association. BHCOE accreditations are being transitioned into ACQ.

Per research published in JAMA Pediatrics (January 2026), private equity firms have acquired more than 500 autism therapy centers over the past decade. Between 2017–2022, PE completed 85% of all M&A in autism services — a rate not found in any other healthcare sector (Cornell/CEPR).